Lab-on-a-Chip market was valued at $6.1 billion in 2024 and is projected to reach $16.3 billion by 2035, growing at a CAGR of 9.4% during the forecast period (2025–2035). The growth of the global lab-on-a-chip market is driven by increasing demand for rapid and accurate diagnostic solutions across healthcare, pharmaceutical, and research sectors. The requirement for point-of-care testing, early disease detection, and decentralized diagnostic systems has led to higher adoption of miniaturized analytical devices. Lab-on-a-chip platforms combine multiple laboratory functions on a single micro-scale chip, which enables faster analytical processes, reduced sample consumption, and lower operational complexity. These systems are used across clinical diagnostics, drug development, and biomedical research applications.
Browse the full report description of “Lab-on-a-Chip Market Size, Share & Trends Analysis Report by Product Type (Reagents & Consumables, and Instruments) by Application (Genomics, Proteomics, Diagnostics, and Drug Discovery) by Technology (DNA Microarrays, and Microfluidic Chip), and By End-User (Hospitals and Diagnostic Labs, Pharmaceutical Companies, and Individuals) Forecast Period (2025-2035)” of https://www.omrglobal.com/industry-reports/lab-on-a-chip-market
Another factor influencing market growth is the prevalence of chronic and infectious diseases, which has increased demand for diagnostic technologies that support early detection and monitoring. According to the World Health Organization (WHO), non-communicable diseases account for approximately 74% of global deaths annually, while infectious diseases continue to affect population health across multiple regions. This has contributed to increased use of lab-on-a-chip devices for molecular diagnostics, immunoassays, and pathogen identification in clinical and research settings.
The expansion of research activities and advancements in microfluidics and nanotechnology also contribute to market development. Increased investment in life sciences research and pharmaceutical research and development has led to greater demand for automated and high-throughput analytical systems. Lab-on-a-chip technologies are used in genomics, proteomics, and cell analysis due to their capacity to perform complex laboratory functions with controlled conditions and reproducible outcomes. These factors are associated with continued adoption of microfluidic-based analytical platforms across academic, clinical, and industrial research environments.
Key Innovators Driving Lab-on-a-Chip Advancements
The key players in the global lab-on-a-chip market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Danaher Corp., Thermo Fisher Scientific, among others. These companies are involved in the design, development, and commercialization of microfluidic and lab?on?a?chip technologies used for rapid diagnostics, clinical testing, genomic analysis, and high?throughput research applications. Their activities encompass product innovation, collaboration with research institutions, and expansion of lab?on?chip platforms to support diverse healthcare and scientific use cases
Market Coverage
Key questions addressed by the report.
Lab-on-a-Chip Market Report Segment
By Product Type
By Application
By Technology
By End User
Lab-on-a-Chip Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lab-on-a-chip-market